EQS Newsfeed

Corpare News, Press, Analysis

Made with ❤ von BGFL
#BGFLapp * beta

EQS News is by far the most important platform for official company news. Boersengefluester.de combines the latest ad-hoc announcements or other company news from our database, meaningful share charts and other useful links from the BGFL data pool, thus creating added value for investors who prefer to obtain timely and meaningful information from the original source. Tip: You are also welcome to use our newsfeed focussing on the latest analyst research to round things off.

09.01.2025 08:28PM

DATAGROUP will not pursue the spin-off of its subsidiary Almato AG

DATAGROUP will not pursue the spin-off of its subsidiary Almato AG Pliezhausen, January 9, 2025. DATAGROUP SE (“DATAGROUP”, WKN A0JC8S) has completed the review of the spin-off of its 100 % stake in Almato AG (“Almato”) to a separate company as a new holding company. DATAGROUP has come to the conclusion that the planned advantages of a spin-off in [ … ]
09.01.2025 03:30PM

Formycon included in TecDAX Index of Deutsche Börse

Press Release // January 9, 2025   Formycon included in TecDAX Index of Deutsche Börse Formycon to join the ranks of the 30 leading listed technology companies Uplisting to the Prime Standard, inclusion in the SDAX, and robust business development further enhance the stock’s appeal Entry into the TecDAX becomes effective as of January 13, 2025  [ … ]
09.01.2025 09:00AM

Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)

PRESS RELEASE   Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)   Biotest's fibrinogen aims to fulfill a high unmet medical need for additional fibrinogen to treat acquired fibrinogen deficiency US submission follows EU application for marketing authorizatio [ … ]
09.01.2025 08:42AM

Delisting of ENCAVIS AG shares from Hamburg Stock Exchange takes effect at the end of 31 January 2025

Corporate NewsDelisting of ENCAVIS AG shares from Hamburg Stock Exchange takes effect at the end of 31 January 2025 Hamburg, 9 January 2025 – The Hamburg Stock Exchange informed ENCAVIS AG (“Encavis” or the “Company”) on 8 January 2025 that it had granted the Company’s application for the revocation of the admission of Encavis shares to trading on  [ … ]
08.01.2025 02:30PM

Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®

Press Release // January 8, 2025 Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi® approved by Health Canada for both subcutaneous and intravenous formulations to treat serious inflammatory diseases Health Canada joins the FDA and the European Commission in gra [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
If desired, the news can be limited to certain indices (DAX, MDAX, etc.) or market segments (Prime Standard, General Standard, Scale, etc.).
Dataselect Tool Family
          EQS Newsfeed          
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL